In this issue:
Talazoparib + enzalutamide for mCRPC
Terbium-161 PSMA radioligand therapy in mCRPC
Metformin for patients with mHSPC starting ADT
Pasritamig for mCRPC
MRI/PET/CT for identifying extent of intraprostatic prostate cancer
Short-term surgical outcomes of radical prostatectomy in the Netherlands
Active surveillance and MRI for GG1 prostate cancer
MRI and long-term outcomes of active surveillance for GG1 prostate cancer
MRI-led risk-adapted active surveillance
Outcomes of salvage RARP
Please login below to download this issue (PDF)